SLC3A2 and ductal breast carcinoma in situ: Moreover, we observed that the upregulation of PSAT1, SLC7A5 and SLC3A2 promoted by expressing doxycycline-inducible mutp53 in DCIS cells was dampened upon silencing of MYC (Suppl.